Advanced Enzyme Technologies Ltd · NSE:ADVENZYMES
Advanced Enzyme Technologies — Q2 FY2019 Earnings Presentation
19 slides from Advanced Enzyme Technologies's earnings presentation, Nov 1, 2018
Slide 1: Advanced Enzyme Technologies Limited Earning Presentation Q2FY19
Advanced Enzyme Technologies Limited Earning Presentation – Q2FY19 | November 2018 Where ENZYME is Life
Slide 2: Disclaimer
Disclaimer This information may contain certain forward-looking statements/details in the current scenario, which is extremely dynamic and increasingly fraught with risks and uncertainties. Actual results, performances, achievements or sequence of events may be materially different from the views ex
Slide 3: Company Overview: What are enzymes?
Company Overview What are enzymes? Enzymes are natural protein molecules that act as catalysts within living cells, produced by all living organisms. Function as specialized catalysts and accelerate the pace of biochemical reactions. Advanced uses enzymes to replace chemicals in, and improve efficie
Slide 4: A Rising Global Star Amongst Top 15 Global Enzyme Companies
Advanced Enzyme Technologies Limited – A Rising Global Star Revenue (₹ mn) 1st Indian enzyme company Highest market share in India Listed integrated enzyme player globally 3,957 2nd 2nd 2,482 Amongst Top 15 Global Enzyme Companies Manufacturing Units – 7 R&D Expenses – 3% FY 14 FY 18 India - 5 USA -
Slide 5: Board of Directors
Board of Directors Mr. Vasant Rathi Mr. Mukund M. Kabra Chairman and Non-Executive Director Whole-time Director Mr. Vasant Laxminarayan Rathi is the Promoter Chairman Mr. Mukund Madhusudan Kabra, is the Whole-time and Non- Executive Director of our Company. He promoted Director of our Company. He is
Slide 6: Board of Directors
Board of Directors Dr. Anil Gupta Mr. Beni Prasad Rauka Mr. Dipak Roda Vice President / Research & Chief Financial Officer Vice President / Market & Business Development Development Mr. Harshad Doshi Mr. Mike Smith Ms. Martina Doering CFO & COO Vice President, Sales & Marketing Managing Director /He
Slide 7: Results Summary – Q2FY19
Results Summary – Q2FY19 Revenue (₹ mn) EBITDA (₹ mn) PAT (₹ mn) 1,032 414 441 986 259 224 Q2FY18 Q2FY19 Q2FY18 Q2FY19 Q2FY18 Q2FY19 Revenue Breakup ₹ in Million *YoY Growth Animal HC Human HC Food Industrial Processing -24% (18%) 9% 1% (47%) 42% 24% Q2FY19 121 770 64 56 Q2FY18 111 761 45 45 Note: 1
Slide 8: Revenue Split – Q2FY19
Revenue Split – Q2FY19 Q2FY19 Q2FY18 Segmental Revenue Split (%) Segmental Revenue Split (%) 6% 6% 12% 5% 5% 11% 76% 79% Animal HC Human HC Food Industrial Processing Animal HC Human HC Food Industrial Processing Geographical Revenue Split (%) Geographical Revenue Split (%) 2% 1% 5% 4% 50% 49% 43% 3
Slide 9: Results Summary – H1FY19
Results Summary – H1FY19 Revenue (₹ mn) EBITDA (₹ mn) PAT (₹ mn) 2,074 929 1,742 712 571 387 H1FY18 H1FY19 H1FY18 H1FY19 H1FY18 H1FY19 Revenue Breakup ₹ in Million *YoY Growth Animal HC Human HC Food Industrial Processing -24% (18%) 16% 18% (47%) 32% 3% Q2FY19 255 1,558 120 98 Q2FY18 220 1,317 91 95
Slide 10: Revenue Split – H1FY19
Revenue Split – H1FY19 H1FY19 H1FY18 Segmental Revenue Split (%) Segmental Revenue Split (%) 5% 12% 5% 5% 13% 6% 77% 77% Animal HC Human HC Food Industrial Processing Animal HC Human HC Food Industrial Processing Geographical Revenue Split (%) Geographical Revenue Split (%) 2% 1% 5% 4% 45% 50% 47% 4
Slide 11: Profit & Loss (Consolidated) – Q2FY19
Profit & Loss (Consolidated) – Q2FY19 ₹ in Million except per share data Q2FY19 Q1FY19 Q2FY18 H1FY19 H1FY18 Particulars Y-o-Y (%) Y-o-Y (%) Unaudited Unaudited Unaudited Unaudited Unaudited Income from Operations 1,032 1,043 986 5% 2,075 1,742 19% Expenses 663 611 622 7% 1,274 1,120 14% Profit from
Slide 12: Balance Sheet (Consolidated) – H1FY19
Balance Sheet (Consolidated) – H1FY19 ₹ in Million H1FY19 H1FY18 Particulars Unaudited Unaudited Assets Property, plant and equipment 1,647 1,683 Capital work-in-progress 103 103 Intangible assets 677 787 Goodwill 2,850 2,419 Other non-current assets 173 176 Current assets 2,725 1,583 Assets held fo
Slide 13: Results Summary – FY18
Results Summary – FY18 Revenue (₹ mn) EBITDA (₹ mn) PAT (₹ mn) 3,957 1,654 1,534 929 936 3,431 FY17 FY18 FY17 FY18 FY17 FY18 Revenue Breakup ₹ in Million *YoY Growth Animal HC Human HC Food Industrial Processing -24% (1%) (10%) (1%) 21% 7% FY18 506 2,892 200 206 FY17 512 2,386 223 193 Note: 1. On Co
Slide 14: Revenue Split – FY18
Revenue Split – FY18 FY18 FY17 Segmental Revenue Split (%) Segmental Revenue Split (%) 5%6% 13% 7% 6% 15% 76% 72% Animal HC Human HC Food Industrial Processing Animal HC Human HC Food Industrial Processing Geographical Revenue Split (%) Geographical Revenue Split (%) 1% 2% 4% 4% 47% 38% 52% 45% 3% 4
Slide 15: Balance Sheet (Consolidated) – FY18
Balance Sheet (Consolidated) – FY18 ₹ in Million FY18 FY17 Particulars Audited Audited Assets Property, plant and equipment 1,667 1,664 Capital work-in-progress 105 80 Intangible assets 662 270 Goodwill 2,584 2,280 Other non-current assets 143 166 Current assets 2,107 1,382 Assets held for sale 48 4
Slide 16: Financial Performance – FY18
Financial Performance – FY18 ₹ in Million Revenue from Operations 2,500 EBIDTA & EBIDTA Margin (%) 50% 47% 42% 48% 3,957 2,000 43% 45% 3,431 46% 2,938 1,500 1,654 1,534 44% 2,394 42% 2,231 1,000 1,389 42% 1,031 931 40% 500 38% 0 36% FY 14 FY 15 FY 16 FY 17 FY 18 FY 14 FY 15 FY 16 FY 17 FY 18 EBIDTA
Slide 17: Strong Financial Performance – FY18
Strong Financial Performance – FY18 Net Working Capital (Days) Net Worth (₹ mn) 128 5,591 4,640 119 112 2,781 109 107 2,120 1,674 FY 14 FY 15 FY 16 FY 17 FY 18 FY 14 FY 15 FY 16 FY 17 FY 18 ROE (%) | ROCE (%) | ROIC (%) Net Debt to Equity (x) 39% 1.0 31% 29% 30% 29% 34% 26% 27% 24% 0.5 28% 28% 0.4 2
Slide 18: Shareholder Information
Shareholder Information Stock Data (As on 31st October 2018) Top 5 Institutional Holders (As on 26th November 2018) Institutions OS (%) Market Capitalization (₹) 22,017 mn HDFC Asset Management Co. Ltd. (Invt Mgmt) 5.55 Shares Outstanding 111.6 mn First State Investment Management Ltd. 1.58 (ICVC) F
Slide 19: Thank You
IR Contact: Supreet Singh Jossan Email: supreet@advancedenzymes.com Advanced Enzyme Technologies Limited 5th Floor, 'A' wing, Sun Magnetica LIC Service Road, Louiswadi, Thane (W) 400 604, India Tel.: +91-22-4170 3200 | Fax: + 91-22-25835159 Web: www.advancedenzymes.com Thank You
Advanced Enzyme Technologies — Q2 FY2019 Earnings Presentation on 6ix